Navigation Links
REMICADE® Receives FDA Approval as First Biologic Treatment for Pediatric Ulcerative Colitis
Date:9/23/2011

the past 17 years and through commercial experience with more than 1.5 million patients treated worldwide.

In the U.S., REMICADE® is approved for the following indications:

  • Reducing signs and symptoms, inhibiting the progression of structural damage and improving physical function in patients with moderately to severely active RA, when administered in combination with methotrexate.  
  • Reducing signs and symptoms in patients with active ankylosing spondylitis.
  • Reducing signs and symptoms and inducing and maintaining clinical remission in adult and pediatric patients with moderately to severely active Crohn's disease who have had an inadequate response to conventional therapy.  
  • Reducing the number of draining enterocutaneous and rectovaginal fistulas and maintaining fistula closure in adult patients with fistulizing Crohn's disease.  
  • Reducing signs and symptoms, inducing and maintaining clinical remission and mucosal healing, and eliminating corticosteroid use in patients with moderately to severely active UC who have had an inadequate response to conventional therapy.
  • Reducing signs and symptoms of active arthritis, inhibiting the progression of structural damage and improving physical function in patients with psoriatic arthritis.  
  • Treatment of adult patients with chronic severe plaque psoriasis who are candidates for systemic therapy and when other systemic therapies are medically less appropriate.

REMICADE® is unique among available anti-TNF-alpha biologic therapies.  It is the only anti-TNF-alpha biologic administered directly by caregivers in the clinic or office setting.  REMICADE® is a two-hour infusion administered every 6 or 8 weeks (indication-dependent), following a standard induction regimen that requires treatment at weeks 0, 2 and 6.  As a result, REMICADE® patients may require as few
'/>"/>

SOURCE Janssen Biotech, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. New Anti-TNF Study Shows Patients With Rheumatoid Arthritis Receiving REMICADE® After Inadequate Response to Enbrel® or Humira® Demonstrate Marked Clinical Improvement
2. Centocor Ortho Biotech Inc. Submits Application to FDA Seeking REMICADE® Pediatric Ulcerative Colitis Indication
3. FDA Advisory Committee Recommends Approval of REMICADE® for Treatment of Pediatric Ulcerative Colitis
4. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
5. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
6. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
7. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
8. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
9. CryoCor Receives FDA Approval for Right Atrial Flutter
10. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
11. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... 3, 2015 The global dermatology treatment devices ... 10.1% from 2014 to 2019. The growth of the ... such as the rising skin disorders, increasing demand for ... factors such as lack of awareness and lack of ... In this report, the global dermatology ...
(Date:6/3/2015)... DIEGO , June 3, 2015  Diomics today ... clandestine service senior official, has joined the company,s board ... of the Intelligence Studies Project and Clinical Professor at ... the University of Texas at Austin. ... from having served 28 years as a member of ...
(Date:6/3/2015)... (NYSE: ACT ), a leading global pharmaceutical company, today ... Actavis, will provide an overview and update of the Company,s ... in Rancho Palos Verdes, Calif. ... presentation will take place on Wednesday, June 10, 2015 at ... Rancho Palos Verdes, Calif.  To access a live ...
Breaking Medicine Technology:Dermatology Treatment Devices Market by Type, by Application - Global Forecast to 2019 2Dermatology Treatment Devices Market by Type, by Application - Global Forecast to 2019 3Former CIA Clandestine Service Senior Official Stephen B. Slick joins Diomics Board of Directors 2Actavis to Present at the Goldman Sachs 36th Annual Global Healthcare Conference 2
... Endo Pharmaceuticals (Nasdaq: ENDP ) today announced ... Food and Drug Administration (FDA) regarding the New Drug Application ... be crush resistant.  The complete response letter did not require ... NDA. "As a result of ongoing discussions ...
... Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR ) announced today ... Conference has been rescheduled for 9:00 a.m. PT on Monday, ... San Francisco. Questcor was originally scheduled to present at 2:00 ... President and Chief Executive Officer, will review the Company,s business ...
Cached Medicine Technology:Endo Pharmaceuticals Provides Regulatory Update on New Formulation of OPANA® ER Designed to be Crush-Resistant 2Endo Pharmaceuticals Provides Regulatory Update on New Formulation of OPANA® ER Designed to be Crush-Resistant 3Endo Pharmaceuticals Provides Regulatory Update on New Formulation of OPANA® ER Designed to be Crush-Resistant 4
(Date:6/3/2015)... MagBelt by Magzook Tightening Systems is now raising funds ... provides a comfortable belt from meetings to mountains. Available in ... 16 color combos to choose from. The MagBelt can also ... , When Denver resident Devin, the creator of MagBelt, realized ... place during long motorcycle rides, he started wondering what else ...
(Date:6/3/2015)... PINES, FL (PRWEB) June 03, 2015 The ... event as part of the Veterans Health Administration’s (VHA) National ... place in the JC Cobb room located on the first ... 10:00 a.m. to 4:00 p.m. Women Veterans and their ... are invited to attend. To download a printable event flyer, ...
(Date:6/3/2015)... 03, 2015 blingsting announces their new ... car's glove compartment or can be strapped onto a ... features a pointed tip that will allow the user ... blade that can cut through a seatbelt or carseat ... Glammer include:, ,         Easily break a window ...
(Date:6/3/2015)... 2015 As of 2014, Japan was ... marketplace. Its share in the Asian market was more ... market in this country is forecast to grow at ... the Asian market is expected to grow at a ... Some of key factors encouraging growth of the marketplace ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 Accountable care ... ACO-based insurance products. Despite initial worries that these product ... with consumers, early signs indicate that product-based ACOs will ... offer explanations why in the June issue of Atlantic ... , “I do think anecdotally that the backlash from ...
Breaking Medicine News(10 mins):Health News:MagBelt Starts Kickstarter for Sliding Magnet Belt 2Health News:Bay Pines to Host National Women Veterans Campaign Event June 12 2Health News:Bay Pines to Host National Women Veterans Campaign Event June 12 3Health News:blingsting Announces All New Car Safety Tool The Glammer 2Health News:Asian Pharmacy Information Systems Market to Grow at a 8.3% CAGR through 2019, Says MicroMarketMonitor in its New Report Available at MarketPublishers.com 2Health News:Product-Based ACOs Are Poised for Growth, Industry Observers Tell AIS Newsletter 2Health News:Product-Based ACOs Are Poised for Growth, Industry Observers Tell AIS Newsletter 3
... to avoid harm , , FRIDAY, April 10 (HealthDay News) -- ... recipe for disaster. , The Soap and Detergent Association ... a more effective cleaner, you might be creating a safety ... those made with natural products, could cause harm to the ...
... and mercury exposure , , SATURDAY, April 11 (HealthDay News) -- ... for optimal maternal health and fetal growth and development. That ... how much seafood moms-to-be can safely consume without exposing their ... of ongoing debate. , The U.S. Food and Drug ...
... Manager online scheduling systems during the first quarter of 2009. , ... ... of Aladtec Inc.), a leader in online employee scheduling solutions for the ... and FIRE Manager customers: , , ,Madison County EMS (VA) ,Lehi Fire ...
... April 11 Following is the daily "Profile America" ... http://www.newscom.com/cgi-bin/prnh/20090226/CENSUSLOGO ) SATURDAY, APRIL 11: DONATE LIFEProfile ... month of spring and resurgence. It,s also National ... donation to give a new lease on life to ...
... Ala. Researchers at the University of Alabama at ... $6.4 million grant from two national nonprofit groups that ... difficult-to-treat form of cancer called "triple negative" breast cancer. ... the Cure and the Triple Negative Breast Cancer Foundation. ...
... can have an impact on patients, experts say , , ... emotional burnout called "compassion fatigue" is common among doctors, ... with cancer, yet experts say little research has been ... cynicism, chronic tiredness, irritability and problem drinking. , Often ...
Cached Medicine News:Health News:Cleaning Concoctions Best Left to Experts 2Health News:How Much Fish to Eat While Pregnant? 2Health News:How Much Fish to Eat While Pregnant? 3Health News:Aladtec Inc Announces New Customers for Online Scheduling Systems -- First Quarter, 2009 2Health News:UAB wins $6.4 million nonprofit grant to fight aggressive breast cancer 2Health News:Stressed Health Care Workers Battle 'Compassion Fatigue' 2Health News:Stressed Health Care Workers Battle 'Compassion Fatigue' 3
Egg-Shaped Bioceramic orbital implants insert easily into orbital socket and will not cling to surrounding tissue. Improved interconnectivity between pores enhances vascularization. Implants may be e...
... Discrete Technology Coronary Stent System provides ... Secure Technology stent retention system features ... encapsulate the stent for added security ... to minimize balloon overhang and to ...
Increased stent scaffolding at the proximal end gives optimal lumen support and 6F guide catheter compatibility and improved tracking offer excellent deliverability. Customized balloon lengths for ea...
For support, strength and control in your interventions, the RunWay Guide Catheter's large lumen and high-performance design represents a new era in guide catheters....
Medicine Products: